SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer

Condition:   Advanced Esophageal Squamous Cell Cancer
Interventions:   Drug: Irinotecan liposome;   Drug: SHR-1316;   Drug: Fluorouracil
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Recruiting

https://ift.tt/2RAyM2b